Abstract
INVITRO EVALUATION OF GEMCITABINE AND ITS DERIVATIVE (GEMCITABINE TRIPHOSPHATE) FOR THE TREATMENT OF PANCREATIC CANCER
Shaik Nazma Sultana*, Dr. Syed Ahmed Hussain, Sara Umm E. Hani, Farahanaaz Begum and Juveria Gaffar
ABSTRACT
This research paper explores the cellular effects of Gemcitabine Triphosphate on cellular viability, tubulogenesis, and protein expression levels. The study employed various assays, including the MTT assay, Tubulogenesis assay, Indirect Immunofluorescence assay, and Western Blot analysis. The research involved four treatment groups: Group 1 (normal), Group 2 (Control cell line), Group 3 (Standard GEMCITABINE), and Group 4 (Gemcitabine Triphosphate). The results indicate that Gemcitabine Triphosphate significantly affects cellular viability, tubulogenesis, and protein expression levels compared to standard GEMCITABINE treatment, underscoring the importance of further research into its effects.
[Full Text Article] [Download Certificate]WJPLS CITATION
All | Since 2019 | |
Citation | 422 | 322 |
h-index | 9 | 7 |
i10-index | 4 | 2 |
INDEXING
NEWS & UPDATION
BEST PAPER AWARDS
World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .
Best Article of current issue
Download Article : Click here